These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14762610)

  • 41. [Hearing loss in autoimmune diseases].
    Klausen OG; Franzén G; Berentsen S
    Tidsskr Nor Laegeforen; 1992 Oct; 112(24):3092-4. PubMed ID: 1471085
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immune-mediated inner ear disorders.
    Moscicki RA
    Baillieres Clin Neurol; 1994 Nov; 3(3):547-63. PubMed ID: 7874408
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sensorineural hearing loss and ulcerative colitis.
    Kumar BN; Walsh RM; Wilson PS; Carlin WV
    J Laryngol Otol; 1997 Mar; 111(3):277-8. PubMed ID: 9156068
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Etanercept, a tumour necrosis factor alpha receptor antagonist, and methotrexate in acute sensorineural hearing loss.
    Street I; Jobanputra P; Proops DW
    J Laryngol Otol; 2006 Dec; 120(12):1064-6. PubMed ID: 17040588
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intratympanic methylprednisolone improves hearing function in refractory sudden sensorineural hearing loss: a control study.
    Li P; Zeng XL; Ye J; Yang QT; Zhang GH; Li Y
    Audiol Neurootol; 2011; 16(3):198-202. PubMed ID: 20948195
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systemic, intratympanic and combined administration of steroids for sudden hearing loss. A prospective randomized multicenter trial.
    Tsounis M; Psillas G; Tsalighopoulos M; Vital V; Maroudias N; Markou K
    Eur Arch Otorhinolaryngol; 2018 Jan; 275(1):103-110. PubMed ID: 29168028
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Autoimmune inner ear disease--a real entity?
    Barna BP; Hughes GB
    Clin Lab Med; 1997 Sep; 17(3):581-94. PubMed ID: 9316775
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intratympanic methylprednisolone for sudden sensorineural hearing loss.
    Kiliç R; Safak MA; Oğuz H; Kargin S; Demirci M; Samim E; Ozlüoğlu LN
    Otol Neurotol; 2007 Apr; 28(3):312-6. PubMed ID: 17414035
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intratympanic methylprednisolone perfusion as a salvage treatment for profound idiopathic sudden sensorineural hearing loss.
    Dai Y; Lu L; Hou J; Yang X; Li H; Yang Y; She W
    J Laryngol Otol; 2017 May; 131(5):404-410. PubMed ID: 28290919
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of evidence for autoimmune pathology of bilateral sudden sensorineural hearing loss using proteomic analysis.
    Lee JM; Kim JY; Bok J; Kim KS; Choi JY; Kim SH
    Clin Immunol; 2017 Oct; 183():24-35. PubMed ID: 28648633
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Autoimmune sensorineural hearing loss as presenting manifestation of paediatric Behçet disease responding to adalimumab: a case report.
    Marsili M; Marzetti V; Lucantoni M; Lapergola G; Gattorno M; Chiarelli F; Breda L
    Ital J Pediatr; 2016 Sep; 42(1):81. PubMed ID: 27600159
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autoimmune sensorineural hearing loss.
    Mathews J; Kumar BN
    Clin Otolaryngol Allied Sci; 2003 Dec; 28(6):479-88. PubMed ID: 14616662
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immune-mediated inner ear disease.
    Bovo R; Aimoni C; Martini A
    Acta Otolaryngol; 2006 Oct; 126(10):1012-21. PubMed ID: 16923703
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Clinician Faced With Anticochlear Antibodies: What to Do With Them?
    Carlomagno A; Silveira G; Rebella M; Vola M; Danza A
    J Clin Rheumatol; 2018 Apr; 24(3):113-115. PubMed ID: 29116948
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Auto-immune sensorineural deafness: physiopathology and therapeutic approach].
    Hervier B; Bordure P; Masseau A; Calais C; Agard C; Hamidou M
    Rev Med Interne; 2010 Mar; 31(3):222-8. PubMed ID: 19233519
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased frequencies of cochlin-specific T cells in patients with autoimmune sensorineural hearing loss.
    Baek MJ; Park HM; Johnson JM; Altuntas CZ; Jane-Wit D; Jaini R; Solares CA; Thomas DM; Ball EJ; Robertson NG; Morton CC; Hughes GB; Tuohy VK
    J Immunol; 2006 Sep; 177(6):4203-10. PubMed ID: 16951386
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Acute bilateral sensorineural hearing loss caused by immuno-mediated inner ear disease].
    Abbate A; Viaggio MB; Piras D; López L; Hubscher O; Nogués M
    Medicina (B Aires); 2001; 61(6):860-2. PubMed ID: 11808429
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Detection of humoral immune response to inner ear proteins in patients with sensorineural hearing loss].
    Naumann A; Hempel JM; Schorn K
    Laryngorhinootologie; 2001 May; 80(5):237-44. PubMed ID: 11417244
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
    Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
    Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autoimmune inner ear disease (AIED): A diagnostic challenge.
    Ciorba A; Corazzi V; Bianchini C; Aimoni C; Pelucchi S; Skarżyński PH; Hatzopoulos S
    Int J Immunopathol Pharmacol; 2018; 32():2058738418808680. PubMed ID: 30376736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.